Hovione

Hovione Contract Manufacturing & Development (CDMO) Profile

Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products.

Hovione has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle.

In the inhalation space, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability.

Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standard

CDMO Services:
Small Molecule; Biologics; Cell & Gene Therapy Drug Substance Manufacturing (API); Drug Product Formulation (FDF); Research & Development; Clinical Trials materials and logistics; Regulatory Services; Analytical Development Inhalers; Liquids; Semi-solids; Soft Gels; Solids

Year Founded: 1959

Head Office: East Windsor, NJ 08520, US

Number of Facilities: 3-5

Facility locations: Europe; North America; China

Website: Visit the Hovione website

Linkedin: Connect on Linkedin

Current Capacity: Hovione have some capacity available, depending on the service